Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Open in API
Filings indexed 940 across all filing types
Latest filing 2023-10-02 Proxy Solicitation & In…
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
Proxy Form (FR-EN).pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document text explicitly mentions 'ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE DES ACTIONNAIRES' (Extraordinary General Shareholders' Meeting) and 'PROCURATION' (Proxy). This material is directly related to soliciting votes or providing representation for a shareholder meeting. The definition for Proxy Solicitation & Information Statement (PSI) covers materials sent to shareholders to provide information and request votes for meetings. While AGM-R covers materials *shared during* the AGM, this document is a proxy form used *before* the meeting to establish representation, fitting best under PSI.
2023-10-02 French
Attendance Form (ENG).pdf
AGM Information Classification · 95% confidence The document is explicitly titled an "ATTENDANCE FORM FOR SECURITY HOLDERS EXTRAORDINARY GENERAL MEETING" and details the procedures, deadlines, and required information for shareholders wishing to attend the EGM scheduled for November 3, 2023. This form is a preparatory document related to soliciting attendance and participation for a general meeting, which aligns closely with the purpose of Proxy Solicitation & Information Statements (PSI) or materials related to an Annual General Meeting (AGM-R). Since it is an attendance form for an *Extraordinary* General Meeting (EGM), and not the final voting results (DVA) or the general AGM presentation materials (AGM-R), it functions as a solicitation/information document for participation. Given the options, AGM-R covers general meeting materials, and PSI covers proxy solicitation. Since this is an attendance form, it is a key component of the solicitation process leading up to the meeting. However, the document is specifically about attending the meeting, which is a core function of proxy materials. Given the context of general meetings, AGM-R is the most appropriate fit for materials related to the general meeting process, even if it's an EGM, as PSI is often reserved for the formal proxy statement itself. Since the document is a form to *attend* the meeting, it is directly related to the general meeting process.
2023-10-02 English
Attendance Form (FR).pdf
AGM Information Classification · 98% confidence The document is explicitly titled "FORMULAIRE DE PARTICIPATION POUR LES TITULAIRES DE TITRES ASSEMBLEE GENERALE EXTRAORDINAIRE" (Participation Form for Security Holders Extraordinary General Meeting). This form is used by shareholders to register their intent to attend and vote at an upcoming Extraordinary General Meeting (EGM) scheduled for November 3, 2023. This material is directly related to the logistics and participation requirements for a shareholder meeting, which falls under the scope of AGM Information (AGM-R), as it pertains to the procedures for attending the general meeting, even if it is an 'Extraordinary' one.
2023-10-02 French
Convening Notice (ENG).pdf
AGM Information Classification · 95% confidence The document is explicitly titled an "INVITATION EXTRAORDINARY GENERAL MEETING" and details the agenda for this meeting, which includes proposed resolutions for a Share Consolidation (1-for-10 reverse stock split) and a De-Listing from Euronext Brussels. The purpose of an Extraordinary General Meeting (EGM) is to seek shareholder approval for significant corporate actions. While the content relates to capital structure changes (SHA/POS) and delisting (DLST), the document itself is the formal notice and agenda for the meeting where these items will be voted upon. This type of material, which solicits shareholder input/attendance for a general meeting, falls under the scope of materials related to shareholder meetings. Since the document is an invitation/agenda for a general meeting, and not the final voting results (DVA) or a presentation (AGM-R, which is usually for the Annual General Meeting), the most appropriate classification is related to general shareholder meetings. Given the options, 'AGM-R' (AGM Information) is the closest fit for general meeting materials, even though it is an EGM, as there is no specific EGM code, and it precedes the actual vote/results.
2023-10-02 English
Convening Notice (FR).pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "INVITATION ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE" (Invitation Extraordinary General Meeting) and details the agenda, date (November 3, 2023), and proposed resolutions for shareholders. The resolutions concern a 1-for-10 reverse stock split ("Regroupement d'Actions") and the delisting from Euronext Brussels ("Radiation de la Cote"). This content is characteristic of materials distributed to shareholders in advance of a general meeting to inform their vote, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to an Extraordinary General Meeting, the primary function here is soliciting votes on specific corporate actions, making PSI more precise than AGM-R (which is usually for the meeting presentation itself).
2023-10-02 French
PR 2023 10 02 EN.pdf
Delisting Announcement Classification · 99% confidence The document is a press release announcing a proposed corporate action: the transition from a dual listing (Nasdaq/Euronext Brussels) to a sole listing on Nasdaq, which involves a reverse stock split, mandatory ADS exchange, and eventual de-listing from Euronext Brussels. Crucially, it explicitly states that shareholder approval is required and convenes an 'extraordinary general shareholders' meeting' for November 3, 2023, to seek these approvals. The text also mentions that further details are available on a dedicated webpage containing a 'Special Report describing the proposals that will be submitted to the Company's extraordinary general shareholders' meeting' and a 'letter from the chair of the board of directors'. Since the document itself is an announcement about an upcoming shareholder meeting and the associated corporate actions (including the need for shareholder approval), it strongly relates to the process of soliciting votes and providing information for that meeting. This aligns best with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it mentions an AGM-related meeting, the core content is the proposal and the call for the meeting, making PSI more specific than AGM-R (which is usually the presentation materials *from* the meeting). It is not a full 10-K, ER, or IR.
2023-10-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.